Clinical Tial of Er:YAG Laser Snoring Treatment
Launched by LUIS MONTEIRO · May 9, 2019
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying the effectiveness of a special laser treatment, called Er:YAG laser, for people who snore. Researchers want to compare two different ways of using this laser to a fake treatment (sham treatment) to see which is more effective in reducing snoring. The trial is currently looking for participants aged 18 and older who snore or have sleep apnea, a condition that can cause breathing problems during sleep. To be eligible, you should not have severe nasal blockages and should have a partner who can provide information about your snoring.
If you join the trial, you will receive either the laser treatment or the sham treatment. Participants will be closely monitored and will need to follow some guidelines regarding food and drinks after the treatment. It’s important to note that certain health conditions, such as throat infections or pregnancy, may prevent someone from participating. This trial aims to find a new solution for snoring, which could potentially help improve sleep quality for many people.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Signed Informed consent form
- • Diagnosis of snoring/apnea including partner information
- • Age greater than 18 years.
- • Apnea-Hypopnea index (AHI) less than 30.
- • No significant nasal stenosis.
- • Bed partner present
- Exclusion Criteria:
- • People who refuse to participate in the study
- • Presence of concomitant disorders and/or diseases
- • Infections in the throat
- • current use of photosensitive drugs
- • pregnancy
- • scarring in the throat
- • acute pollen allergies
- • epilepsy
- • People starting with an extreme diet or weight loss plan
- • Patients who do not want to follow post treatment recommendation concerning food and drinks intake
- • Larynx obstruction (floppy epiglottis)
- • Oropharynx obstruction caused by palatine tonsils (\>50%).
About Luis Monteiro
Luis Monteiro is a dedicated clinical trial sponsor committed to advancing medical research and improving patient outcomes through innovative clinical studies. With a strong focus on ethical practices and regulatory compliance, Luis Monteiro leads initiatives that explore new therapeutic approaches across various therapeutic areas. His expertise in trial design and execution ensures robust data collection and analysis, fostering collaboration among researchers, healthcare professionals, and regulatory bodies. Through a patient-centered approach, Luis Monteiro aims to contribute to the development of safe and effective treatments that address unmet medical needs.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Porto, , Portugal
Patients applied
Trial Officials
Luis Monteiro, DMD, PhD
Principal Investigator
Instituto Universitário de Ciências da Saude, CESPU
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials